In this case Moderna’s mRNA-1273 vaccine instructs the body to make antibodies against a stabilised form of the Spike (S) protein found on the SARS-CoV-2 virus. The phase 1 study is being ...

4/5 and ancestral SARS-CoV-2 than mRNA-1273, with the highest geometric mean titer ratios observed in adults and in the subset of participants aged 65 years and older,” Moderna said. The new ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

The researchers identified 1248 major structural birth defects among 78,052 pregnancies: 1049 in unvaccinated people and 199 in vaccinated people (160.6 and 156.4 per 10,000 live births, respectively) ...

The data demonstrated a higher immune response against SARS-CoV-2 than mRNA-1273.222, Moderna’s licensed COVID-19 vaccine. “We are excited to announce our fourth infectious disease vaccine ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Moderna's preferred solution is mRNA-1273,214, a prototype that is in an advanced stage of study and combines the serum of the original vaccine with another specific one against the Ómicron variant.

The Moderna laboratories Tuesday reported that their two bivalent Omicron-targeting new messenger RNA (mRNA) technology booster vaccines (mRNA-1273.214 and mRNA-1273.222) have a superior antibody ...